Changes in the Phytoalexin Content of Various Vitis Spp. in Response to Ultraviolet C Elicitation-Reference-Cited by-同舟云学术

Changes in the Phytoalexin Content of Various Vitis Spp. in Response to Ultraviolet C Elicitation

Published:1999-09-23 Issue:10 Volume:47 Page:4456-4461
ISSN:0021-8561
Container-title:Journal of Agricultural and Food Chemistry
language:en
Short-container-title:J. Agric. Food Chem.

Author:

Douillet-Breuil Anne-Céline¹,Jeandet Philippe¹,Adrian Marielle¹,Bessis Roger¹

Affiliation:

1. Laboratoire des Sciences de la Vigne, Institut Universitaire de la Vigne et du Vin, Université de Bourgogne, B.P. 27-877, 21078 Dijon Cedex, France, and Laboratoire d'Oenologie, UFR Sciences Exactes et Naturelles, Moulin de la Housse, Université de Reims, B.P. 1039, 51687 Reims Cedex 02, France

Publisher

American Chemical Society (ACS)

Subject

General Agricultural and Biological Sciences,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/jf9900478

Reference35 articles.

1. Induction of Phytoalexin (Resveratrol) Synthesis in Grapevine Leaves Treated with Aluminum Chloride (AlCl3)

2. Biological Activity of Resveratrol, a Stilbenic Compound from Grapevines, Against Botrytis cinerea, the Causal Agent for Gray Mold

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of some physiological and chemical changes in shoots and leaves caused by UV-C radiation as an abiotic stress source in grapevine cuttings;Scientia Horticulturae;2024-10

2. UV-C treatment elicits resistant responses against Botrytis cinerea infection and the improvement of fruit characteristics in grapevines;Horticulture, Environment, and Biotechnology;2024-04-16

3. Grapevine defence mechanisms when challenged by pathogenic fungi and oomycetes;Advances in Botanical Research;2024

4. Use of Elicitors and Beneficial Bacteria to Induce and Prime the Stilbene Phytoalexin Response: Applications to Grapevine Disease Resistance;Agronomy;2023-08-25

5. Resveratrol in Cancer Treatment with a Focus on Breast Cancer;Current Molecular Pharmacology;2023-06